Managing Master Alarm Protein Gal-3,
a Source of Degenerative Disease
Isaac Eliaz, MD, MS, LAc
What to expect
Modulation of Gal-3 can influence pathogenic processes at work, which makes Gal-3 an important diagnostic and prognostic biomarker. Join Isaac Eliaz, MD, a recognized expert in Gal-3 research, to learn how to utilize this important integrative tool in clinical practice. In this presentation you will learn:
• Gal-3’s role in degenerative disease
• How modulation of Gal-3 can inhibit pathogenic processes and enhance efficacy of certain classes of drugs
• The clinical evidence behind modified citrus pectin (MCP), a natural inhibitor of Gal-3
• Evidence-based protocols using a Gal-3 inhibition approach
Don’t miss this opportunity with Dr. Eliaz to benefit from his extensive experience with Gal-3 inhibition in integrative medicine and integrative oncology.
Isaac Eliaz, MD, MS, Lac
Isaac Eliaz, MD, MS, LAc (acupuncture), has been in clinical practice for over 30 years with a focus on integrative approaches to cancer and chronic diseases. He is the medical director of Amitabha Medical Clinic and Healing Center in Santa Rosa, CA, where he and his team have pioneered the application of innovative treatments for complex degenerative conditions. His research activities include collaboration with leading academic and medical institutions such as Harvard, MD Anderson, Columbia, Tufts, the USDA, and others worldwide. As an internationally recognized expert in the role of Gal-3 in health and disease, Dr. Eliaz has coauthored numerous peer-reviewed papers, is a frequent CME lecturer at international scientific conferences, and enjoys fostering the translation of leading-edge research into practical clinical tools. His multidisciplinary background in Western medicine, traditional Chinese and Tibetan medicine, Western herbology, homeopathy, yoga, qigong, and meditation brings a unique perspective to his clinical practice.